• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶抑制剂炭色蠕孢菌(HC)毒素可抑制神经母细胞瘤细胞的恶性表型。

Histone deacetylase inhibitor Helminthosporium carbonum (HC)-toxin suppresses the malignant phenotype of neuroblastoma cells.

作者信息

Deubzer Hedwig E, Ehemann Volker, Westermann Frank, Heinrich Ralf, Mechtersheimer Gunhild, Kulozik Andreas E, Schwab Manfred, Witt Olaf

机构信息

Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

出版信息

Int J Cancer. 2008 Apr 15;122(8):1891-900. doi: 10.1002/ijc.23295.

DOI:10.1002/ijc.23295
PMID:18074352
Abstract

The survival rate of children with advanced neuroblastoma (NB) is dismal despite intensive multimodal therapy. The limited efficacy and the frequent and serious side effects of currently used therapeutic regimens necessitate the development of new, less toxic treatment strategies. This study shows that the histone deacetylase inhibitor Helminthosporium carbonum (HC)-toxin suppresses the malignant phenotype of both established NB cell lines and primary NB cells with and without amplified MYCN at dosages lower than 20 nM. HC-toxin induces cell cycle arrest and apoptosis as well as neuronal differentiation and diminishes both colony formation and invasive growth. These cellular changes are accompanied by the transcriptional repression of cell cycle regulators of the retinoblastoma (RB) tumor suppressor network found at high levels in NBs with poor prognosis, like E2F-1 and its targets Skp2, N-myc, Mad2 and survivin. The levels of the hypophosphorylated active form of RB, and of cyclin-dependent kinase inhibitors including p15(INK4b), p16(INK4a), p21(cip1/waf-1) and p27(kip1) are increased. In conclusion, nanomolar doses of the HDACI HC-toxin cause a shift to a differentiated and benign phenotype of NB cells that is associated with an activation of the RB tumor suppressor network.

摘要

尽管采用了强化多模式疗法,晚期神经母细胞瘤(NB)患儿的生存率依然很低。目前使用的治疗方案疗效有限且频繁出现严重副作用,因此有必要开发毒性更低的新治疗策略。本研究表明,组蛋白脱乙酰酶抑制剂炭疽长蠕孢(HC)毒素在剂量低于20 nM时,可抑制已建立的NB细胞系以及有无MYCN扩增的原代NB细胞的恶性表型。HC毒素诱导细胞周期停滞和凋亡以及神经元分化,并减少集落形成和侵袭性生长。这些细胞变化伴随着视网膜母细胞瘤(RB)肿瘤抑制网络的细胞周期调节因子的转录抑制,这些调节因子在预后不良的NB中高水平存在,如E2F-1及其靶标Skp2、N-myc、Mad2和存活素。RB的低磷酸化活性形式以及包括p15(INK4b)、p16(INK4a)、p21(cip1/waf-1)和p27(kip1)在内的细胞周期蛋白依赖性激酶抑制剂的水平升高。总之,纳摩尔剂量的HDACI HC毒素会使NB细胞转变为分化型和良性表型,这与RB肿瘤抑制网络的激活有关。

相似文献

1
Histone deacetylase inhibitor Helminthosporium carbonum (HC)-toxin suppresses the malignant phenotype of neuroblastoma cells.组蛋白去乙酰化酶抑制剂炭色蠕孢菌(HC)毒素可抑制神经母细胞瘤细胞的恶性表型。
Int J Cancer. 2008 Apr 15;122(8):1891-900. doi: 10.1002/ijc.23295.
2
Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitro.炭疽蠕孢菌(HC)毒素对神经母细胞瘤的体外抑制活性优于其他具有分化诱导作用的化合物。
Cancer Lett. 2008 Jun 8;264(1):21-8. doi: 10.1016/j.canlet.2008.01.002. Epub 2008 Feb 8.
3
p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.p21Waf1/Cip1是短链脂肪酸组蛋白去乙酰化酶抑制剂(丙戊酸、三丁酸甘油酯和丁酸钠)在神经母细胞瘤细胞中诱导产生的一个共同靶点。
Oncol Rep. 2005 Jun;13(6):1139-44.
4
Histone deacetylase inhibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins.组蛋白去乙酰化酶抑制剂BL1521通过改变细胞周期蛋白的表达诱导神经母细胞瘤细胞G1期阻滞。
FEBS Lett. 2005 Feb 28;579(6):1523-8. doi: 10.1016/j.febslet.2005.01.058.
5
Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells.p27Kip1、视网膜母细胞瘤蛋白Rb和MYCN在多胺抑制剂诱导的MYCN扩增人神经母细胞瘤细胞G1期细胞周期阻滞中的关键作用。
Oncogene. 2005 Aug 25;24(36):5606-18. doi: 10.1038/sj.onc.1208808.
6
Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells.组蛋白去乙酰化酶抑制诱导人神经母细胞瘤细胞凋亡和自噬。
Cancer Lett. 2012 May 1;318(1):42-52. doi: 10.1016/j.canlet.2011.11.036. Epub 2011 Dec 17.
7
Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells.视黄酸和组蛋白去乙酰化酶抑制剂对人神经母细胞瘤SH-SY5Y细胞的联合作用。
Mol Cancer Ther. 2007 Apr;6(4):1425-32. doi: 10.1158/1535-7163.MCT-06-0623.
8
Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells.组蛋白去乙酰化酶(HDAC)抑制剂可恢复神经母细胞瘤细胞中的p53信号通路。
Br J Pharmacol. 2008 Feb;153(4):657-68. doi: 10.1038/sj.bjp.0707608. Epub 2007 Dec 3.
9
Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest.人类神经母细胞瘤细胞中Ras与MycN之间合作关系的破坏会促进生长停滞。
Clin Cancer Res. 2005 Jun 15;11(12):4321-30. doi: 10.1158/1078-0432.CCR-04-2071.
10
Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.组蛋白去乙酰化酶抑制剂通过半胱天冬酶依赖性地增加促凋亡蛋白与抗凋亡蛋白的比例,使神经母细胞瘤细胞对TRAIL诱导的凋亡高度敏感。
BMC Cancer. 2006 Aug 24;6:214. doi: 10.1186/1471-2407-6-214.

引用本文的文献

1
HDAC2 promotes autophagy-associated HCC malignant progression by transcriptionally activating LAPTM4B.HDAC2 通过转录激活 LAPTM4B 促进自噬相关 HCC 恶性进展。
Cell Death Dis. 2024 Aug 15;15(8):593. doi: 10.1038/s41419-024-06981-3.
2
Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy.表观遗传药物重新利用:在癌症治疗中发现旧相识的新面孔。
Front Oncol. 2020 Nov 18;10:605386. doi: 10.3389/fonc.2020.605386. eCollection 2020.
3
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma.
神经母细胞瘤中的组蛋白去乙酰化酶和组蛋白去乙酰化酶抑制剂
Front Cell Dev Biol. 2020 Oct 7;8:578770. doi: 10.3389/fcell.2020.578770. eCollection 2020.
4
Natural Products Impacting DNA Methyltransferases and Histone Deacetylases.影响DNA甲基转移酶和组蛋白脱乙酰酶的天然产物。
Front Pharmacol. 2020 Aug 13;11:992. doi: 10.3389/fphar.2020.00992. eCollection 2020.
5
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability.组蛋白去乙酰化酶(HDACs):进化、特异性、在转录复合物中的作用和药物作用。
Genes (Basel). 2020 May 15;11(5):556. doi: 10.3390/genes11050556.
6
Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?将旧药重新用作新型表观遗传抑制剂:癌症治疗的有望候选药物?
Pharmaceutics. 2020 Apr 29;12(5):410. doi: 10.3390/pharmaceutics12050410.
7
Using droplet digital PCR to analyze and copy number in plasma from patients with neuroblastoma.使用液滴数字PCR分析神经母细胞瘤患者血浆中的拷贝数。
Oncotarget. 2017 Jul 7;8(49):85234-85251. doi: 10.18632/oncotarget.19076. eCollection 2017 Oct 17.
8
Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma.乙酰唑胺增强了组蛋白去乙酰化酶抑制剂MS-275在神经母细胞瘤中的抗肿瘤潜力。
BMC Cancer. 2017 Feb 24;17(1):156. doi: 10.1186/s12885-017-3126-7.
9
Histone deacetylase inhibitor screening identifies HC toxin as the most effective in intrahepatic cholangiocarcinoma cells.组蛋白去乙酰化酶抑制剂筛选确定HC毒素是肝内胆管癌细胞中最有效的。
Oncol Rep. 2016 May;35(5):2535-42. doi: 10.3892/or.2016.4636. Epub 2016 Feb 25.
10
Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapies.利用来自多个结直肠癌数据集的组合基因特征进行连接性图谱分析,确定了包括现有化疗药物在内的候选药物。
BMC Syst Biol. 2015;9 Suppl 5(Suppl 5):S4. doi: 10.1186/1752-0509-9-S5-S4. Epub 2015 Sep 1.